DOI:

Biodegradable drug eluting stents: invasive and non-invasive imaging

Neville Kukreja, MA, MRCP; Masato Otsuka, MD; Carlos van Mieghem, MD; Jurgen Ligthart, BSc; Georgios Sianos, MD PhD; Patrick W. Serruys*, MD, PhD

A biodegradable everolimus-eluting stent, developed by Bioabsorbable Vascular Solutions, Inc., an affiliate of Abbott Laboratories, located in Mountain View, CA, is currently undergoing clinical evaluation. The stent consists of a Polylactic acid (PLA) stent backbone processed for increased radial strength to provide stent integrity and a thin amorphous everolimus/PLA matrix coating (1:1 ratio of Everolimus/PLA matrix) for controlled drug release. Panel (a) shows the stent ex vivo: the stent is transparent apart from 2 radio-opaque markers at both proximal and distal edges. The appearances on optical coherence tomography (OCT) (Panel b) are quite unlike conventional stents; OCT can detect the interface between the stent and other tissues or fluid, but the inside of the strut consists of exactly the same material all the way through so it appears black, giving this a unique box appearance. The stent is radiolucent and invisible on fluoroscopy and multi-slice computed tomography (MSCT). Panels (c) and (d) demonstrate that the radiopaque markers (arrows) are clearly visible on MSCT, although due to a blooming effect the 2 markers appear as one continuous object. Calcification can be seen in the vessel proximal to the stent.

Volume 2 Number 3
Nov 20, 2006
Volume 2 Number 3
View full issue


Key metrics

Suggested by Cory

Editorial

10.4244/EIJ-E-24-00052 Nov 18, 2024
Low-flow, low-gradient aortic stenosis: an understanding is still a long way off
Webb J and Offen S
free

Debate

10.4244/EIJ-E-24-00054 Nov 18, 2024
TAVI patients with bystander coronary artery disease should receive PCI: pros and cons
Rodés-Cabau J et al
free

EAPCI Column

Nov 18, 2024
EAPCI at PCR London Valves 2024
free

Original Research

10.4244/EIJ-D-24-00442 Nov 18, 2024
Long-term survival after TAVI in low-flow, low-gradient aortic valve stenosis
Cardaioli F et al

Original Research

10.4244/EIJ-D-24-00367 Nov 18, 2024
Feasibility of redo-TAVI in the self-expanding ACURATE neo2 valve: a computed tomography study
Bieliauskas G et al
Trending articles
152.9

Clinical research

10.4244/EIJ-D-20-01125 Oct 20, 2021
An upfront combined strategy for endovascular haemostasis in transfemoral transcatheter aortic valve implantation
Costa G et al
free
47.8

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
39.1

Clinical research

10.4244/EIJ-D-22-00558 Feb 6, 2023
Permanent pacemaker implantation and left bundle branch block with self-expanding valves – a SCOPE 2 subanalysis
Pellegrini C et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved